This document is an excerpt from the EUR-Lex website
Document 52021XC1126(04)
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2021 to 31 October 2021 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)
Eiropas Savienības lēmumu kopsavilkums par zāļu tirdzniecības atļaujām no 2021. gada 1. oktobra līdz 2021. gada 31. oktobrim (publicēts saskaņā ar 13. vai 38. pantu Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004)
Eiropas Savienības lēmumu kopsavilkums par zāļu tirdzniecības atļaujām no 2021. gada 1. oktobra līdz 2021. gada 31. oktobrim (publicēts saskaņā ar 13. vai 38. pantu Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004)
PUB/2021/917
OV C 478, 26.11.2021, p. 1–7
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
26.11.2021 |
LV |
Eiropas Savienības Oficiālais Vēstnesis |
C 478/1 |
Eiropas Savienības lēmumu kopsavilkums par zāļu tirdzniecības atļaujām no 2021. gada 1. oktobra līdz 2021. gada 31. oktobrim
(publicēts saskaņā ar 13. vai 38. pantu Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004 (1))
(2021/C 478/01)
— Tirdzniecības atļaujas grozīšana (13. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004): Pieņemtas
Lēmuma datums |
Zāļu nosaukums |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Paziņojuma datums |
||
1.10.2021. |
COVID-19 Vaccine Janssen |
|
EU/1/20/1525 |
1.10.2021. |
||
4.10.2021. |
Docetaxel Accord |
|
EU/1/12/769 |
5.10.2021. |
||
4.10.2021. |
Docetaxel Kabi |
|
EU/1/12/770 |
6.10.2021. |
||
4.10.2021. |
Posaconazole Accord |
|
EU/1/19/1379 |
5.10.2021. |
||
4.10.2021. |
Spikevax |
|
EU/1/20/1507 |
4.10.2021. |
||
5.10.2021. |
Comirnaty |
|
EU/1/20/1528 |
5.10.2021. |
||
5.10.2021. |
Spikevax |
|
EU/1/20/1507 |
5.10.2021. |
||
11.10.2021. |
Copalia |
|
EU/1/06/372 |
12.10.2021. |
||
11.10.2021. |
COVID-19 Vaccine Janssen |
|
EU/1/20/1525 |
11.10.2021. |
||
11.10.2021. |
Dafiro |
|
EU/1/06/371 |
12.10.2021. |
||
11.10.2021. |
Entecavir Mylan |
|
EU/1/17/1227 |
12.10.2021. |
||
11.10.2021. |
Equidacent |
|
EU/1/20/1472 |
8.11.2021. |
||
11.10.2021. |
Exforge |
|
EU/1/06/370 |
12.10.2021. |
||
11.10.2021. |
Onpattro |
|
EU/1/18/1320 |
13.10.2021. |
||
11.10.2021. |
Ovitrelle |
|
EU/1/00/165 |
12.10.2021. |
||
11.10.2021. |
ReFacto AF |
|
EU/1/99/103 |
12.10.2021. |
||
11.10.2021. |
Sifrol |
|
EU/1/97/050 |
14.10.2021. |
||
11.10.2021. |
Vargatef |
|
EU/1/14/954 |
27.10.2021. |
||
11.10.2021. |
Vyndaqel |
|
EU/1/11/717 |
12.10.2021. |
||
15.10.2021. |
Vaxzevria |
|
EU/1/21/1529 |
15.10.2021. |
||
19.10.2021. |
Ammonaps |
|
EU/1/99/120 |
20.10.2021. |
||
19.10.2021. |
Busilvex |
|
EU/1/03/254 |
20.10.2021. |
||
19.10.2021. |
Ceprotin |
|
EU/1/01/190 |
20.10.2021. |
||
19.10.2021. |
Clopidogrel/Acetylsalicylic acid Mylan |
|
EU/1/19/1395 |
20.10.2021. |
||
19.10.2021. |
Duloxetine Mylan |
|
EU/1/15/1010 |
21.10.2021. |
||
19.10.2021. |
Ecalta |
|
EU/1/07/416 |
20.10.2021. |
||
19.10.2021. |
Erelzi |
|
EU/1/17/1195 |
20.10.2021. |
||
19.10.2021. |
Firmagon |
|
EU/1/08/504 |
25.10.2021. |
||
19.10.2021. |
Forsteo |
|
EU/1/03/247 |
25.10.2021. |
||
19.10.2021. |
Gazyvaro |
|
EU/1/14/937 |
20.10.2021. |
||
19.10.2021. |
Gefitinib Mylan |
|
EU/1/18/1321 |
20.10.2021. |
||
19.10.2021. |
Hefiya |
|
EU/1/18/1287 |
20.10.2021. |
||
19.10.2021. |
Imfinzi |
|
EU/1/18/1322 |
21.10.2021. |
||
19.10.2021. |
Inrebic |
|
EU/1/20/1514 |
21.10.2021. |
||
19.10.2021. |
Integrilin |
|
EU/1/99/109 |
20.10.2021. |
||
19.10.2021. |
KEYTRUDA |
|
EU/1/15/1024 |
21.10.2021. |
||
19.10.2021. |
Lopinavir/Ritonavir Mylan |
|
EU/1/15/1067 |
21.10.2021. |
||
19.10.2021. |
Memantine LEK |
|
EU/1/13/826 |
21.10.2021. |
||
19.10.2021. |
Memantine Mylan |
|
EU/1/13/827 |
20.10.2021. |
||
19.10.2021. |
Mirapexin |
|
EU/1/97/051 |
21.10.2021. |
||
19.10.2021. |
Myozyme |
|
EU/1/06/333 |
25.10.2021. |
||
19.10.2021. |
NovoEight |
|
EU/1/13/888 |
21.10.2021. |
||
19.10.2021. |
NovoMix |
|
EU/1/00/142 |
21.10.2021. |
||
19.10.2021. |
Noxafil |
|
EU/1/05/320 |
21.10.2021. |
||
19.10.2021. |
OPDIVO |
|
EU/1/15/1014 |
9.11.2021. |
||
19.10.2021. |
Prasugrel Mylan |
|
EU/1/18/1273 |
20.10.2021. |
||
19.10.2021. |
Rasagiline Mylan |
|
EU/1/16/1090 |
20.10.2021. |
||
19.10.2021. |
REKAMBYS |
|
EU/1/20/1482 |
20.10.2021. |
||
19.10.2021. |
Repaglinide Krka |
|
EU/1/09/579 |
21.10.2021. |
||
19.10.2021. |
Semglee |
|
EU/1/18/1270 |
20.10.2021. |
||
19.10.2021. |
Spedra |
|
EU/1/13/841 |
21.10.2021. |
||
19.10.2021. |
Sunosi |
|
EU/1/19/1408 |
21.10.2021. |
||
19.10.2021. |
Tasmar |
|
EU/1/97/044 |
21.10.2021. |
||
19.10.2021. |
Tenofovir disoproxil Mylan |
|
EU/1/16/1129 |
20.10.2021. |
||
19.10.2021. |
Torisel |
|
EU/1/07/424 |
20.10.2021. |
||
19.10.2021. |
Vaborem |
|
EU/1/18/1334 |
20.10.2021. |
||
19.10.2021. |
Vfend |
|
EU/1/02/212 |
21.10.2021. |
||
19.10.2021. |
Vocabria |
|
EU/1/20/1481 |
20.10.2021. |
||
19.10.2021. |
Xydalba |
|
EU/1/14/986 |
20.10.2021. |
||
19.10.2021. |
Zessly |
|
EU/1/18/1280 |
20.10.2021. |
||
22.10.2021. |
Adempas |
|
EU/1/13/907 |
5.11.2021. |
||
22.10.2021. |
Alofisel |
|
EU/1/17/1261 |
28.10.2021. |
||
22.10.2021. |
Betaferon |
|
EU/1/95/003 |
5.11.2021. |
||
22.10.2021. |
Biktarvy |
|
EU/1/18/1289 |
27.10.2021. |
||
22.10.2021. |
Clopidogrel ratiopharm |
|
EU/1/14/975 |
26.10.2021. |
||
22.10.2021. |
Hyrimoz |
|
EU/1/18/1286 |
25.10.2021. |
||
22.10.2021. |
Idacio |
|
EU/1/19/1356 |
25.10.2021. |
||
22.10.2021. |
Imcivree |
|
EU/1/21/1564 |
26.10.2021. |
||
22.10.2021. |
Inflectra |
|
EU/1/13/854 |
25.10.2021. |
||
22.10.2021. |
Jardiance |
|
EU/1/14/930 |
25.10.2021. |
||
22.10.2021. |
Retacrit |
|
EU/1/07/431 |
25.10.2021. |
||
22.10.2021. |
Steglatro |
|
EU/1/18/1267 |
25.10.2021. |
||
22.10.2021. |
Veltassa |
|
EU/1/17/1179 |
9.11.2021. |
||
22.10.2021. |
Zepatier |
|
EU/1/16/1119 |
25.10.2021. |
||
25.10.2021. |
Clopidogrel Taw Pharma |
|
EU/1/09/559 |
26.10.2021. |
||
25.10.2021. |
Clopidogrel Viatris |
|
EU/1/09/568 |
1.11.2021. |
||
25.10.2021. |
Firazyr |
|
EU/1/08/461 |
27.10.2021. |
||
25.10.2021. |
Forxiga |
|
EU/1/12/795 |
26.11.2021. |
||
25.10.2021. |
Latuda |
|
EU/1/14/913 |
26.10.2021. |
||
25.10.2021. |
Nerlynx |
|
EU/1/18/1311 |
10.11.2021. |
||
25.10.2021. |
Segluromet |
|
EU/1/18/1265 |
28.10.2021. |
||
25.10.2021. |
Zyllt |
|
EU/1/09/553 |
27.10.2021. |
||
28.10.2021. |
Clopidogrel Krka |
|
EU/1/09/556 |
2.11.2021. |
||
28.10.2021. |
Clopidogrel TAD |
|
EU/1/09/555 |
3.11.2021. |
||
28.10.2021. |
Darunavir Mylan |
|
EU/1/16/1140 |
5.11.2021. |
||
28.10.2021. |
Mysildecard |
|
EU/1/16/1134 |
29.10.2021. |
||
28.10.2021. |
Ontozry |
|
EU/1/21/1530 |
29.10.2021. |
||
28.10.2021. |
Tyverb |
|
EU/1/07/440 |
29.10.2021. |
||
28.10.2021. |
Voriconazole Accord |
|
EU/1/13/835 |
29.10.2021. |
||
29.10.2021. |
Spikevax |
|
EU/1/20/1507 |
29.10.2021. |
— Tirdzniecības atļaujas izņemšana no aprites (13. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004)
Lēmuma datums |
Zāļu nosaukums |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Paziņojuma datums |
||
11.10.2021. |
Docetaxel Teva |
|
EU/1/09/611 |
12.10.2021. |
||
11.10.2021. |
Equidacent |
|
EU/1/20/1472 |
8.11.2021. |
— Tirdzniecības atļaujas grozīšana (38. pants Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004): Pieņemtas
Lēmuma datums |
Zāļu nosaukums |
Tirdzniecības atļaujas turētājs |
Ieraksta numurs Kopienas reģistrā |
Paziņojuma datums |
||
18.10.2021. |
Oxyglobin |
|
EU/2/99/015 |
5.11.2021. |
||
25.10.2021. |
Activyl Tick Plus |
|
EU/2/11/137 |
26.10.2021. |
||
25.10.2021. |
Canigen L4 |
|
EU/2/15/183 |
26.10.2021. |
||
25.10.2021. |
Nobilis IB Primo QX |
|
EU/2/14/174 |
27.10.2021. |
||
25.10.2021. |
Tulissin |
|
EU/2/20/252 |
28.10.2021. |
||
25.10.2021. |
Vectra 3D |
|
EU/2/13/156 |
26.10.2021. |
Ikvienam, kurš vēlas apskatīt publisko novērtējuma ziņojumu par attiecīgajām zālēm un ar tām saistītos lēmumus, jāsazinās ar:
European Medicines Agency |
Domenico Scarlattilaan 6 |
1083 HS Amsterdam |
NETHERLANDS |